6 presentaciones / Moderadores 13 videos 1 pase
Premium

Pr Uwe PAASCH

Dermatólogo
Alemania

Prof. Paasch received his academic training at the University of Leipzig. Since 2001 he serves as senior physician at the Department of Dermatology and Venerology at the University of Leipzig and visiting professor Bispebjerg University Hospital Copenhagen. In his current position he oversees the activities of the andrology. Professor Paasch has been publishing numerous scientific papers in the field of cutaneous lasers applications, cell biology and in immunohistochemistry methods. Since 2015 he serves as medical director of hautaerzte-paasch.de a specialized practise for general, surgical and aesthetic dermatology next to the laser research Institute Tiliaderm.

leer más
add item Agregar Uwe PAASCH

Uwe PAASCH's presentaciones (13)

Uwe PAASCH's informes (54)

Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels.

01, 2018

Laser treatment in the early phases of wound healing may reduce scar formation. However, little is known on when in the early wound healing phases laser exposure most optimally should be provided and at which fluence levels. This study investigates the clinical effect of non-ablative-fractional-laser (NAFL) performed at three early time points at a range of fluence levels versus untreated control scars. leer más

Lasers in surgery and medicine

Laser-induced thermal coagulation enhances skin uptake of topically applied compounds.

08, 2017

Ablative fractional laser (AFL) generates microchannels in skin surrounded by a zone of thermally altered tissue, termed the coagulation zone (CZ). The thickness of CZ varies according to applied wavelength and laser settings. It is well-known that AFL channels facilitate uptake of topically applied compounds, but the importance of CZ is unknown. leer más

Lasers in surgery and medicine

New lasers and light sources - old and new risks?

May, 2017

Recent developments (new wavelengths, treatment concepts, and combinations) in the field of lasers, intense pulsed light (IPL), LED, as well as new energy and light sources have opened up new therapeutic options that extend beyond mere aesthetic indications. Thus, while fractional lasers used to be employed to merely treat wrinkles, the same devices - in the context of laser-assisted drug delivery - have now become important tools in the treatment of scars, field cancerization, and epithelial tumors. The requirements posed to physicians, both with respect to establishing the indication and conducting treatment, have been growing along with the increase in technological complexity as well as the rising number of comorbidities and comedications in a patient population that continues to age. At the same time, home-use devices have been introduced for a variety of indications. These devices are characterized by low power and special safety features aimed at preventing accidents, risks, and side effects. Despite the reduced efficacy of such self-treatment devices, there is an increased risk of misuse, given that the basic prerequisite for adequate treatment cannot be ensured, to wit, the exact diagnosis and therapeutic indication. Consequently, during hair removal or anti-wrinkle treatment, pigmented lesions and cutaneous neoplasms may be altered, thus giving rise to expected, unexpected and new side effects and complications. In the aforementioned setting, it is important that all potential users of these new technologies be properly trained in a manner that ensures those treated a maximum of safety and efficacy in accordance with the guiding principle "diagnosis certa - ullae therapiae fundamentum". leer más

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Ver más